Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata
Status:
Completed
Trial end date:
2018-11-06
Target enrollment:
Participant gender:
Summary
The main objective of this study is to assess the safety, tolerability and efficacy of
ATI-50002 Topical Solution in subjects with unilateral or bilateral loss of eyebrow hair due
to alopecia areata (AA), alopecia universalis (AU) or alopecia totalis (AT).